| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Emmaus Life Sciences, Inc. | CSO & EVP Clinical Development | Options | 200K | $30K | $0.15 | 01 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | 01 Feb 2024 | 1 | $30K | 4 | CSO & EVP Clinical Development | 05 Feb 2024, 16:37 |
| EMMA | Emmaus Life Sciences, Inc. | 12 Jan 2023 | 1 | $450K | 4 | SVP, Clinical Development | 17 Jan 2023, 13:32 |
| EMMA | Emmaus Life Sciences, Inc. | 23 Nov 2021 | 0 | $0 | 3 | SVP, Clinical Development | 28 Dec 2021, 18:37 |